Response to pazopanib-based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma.
Clin Case Rep
; 9(11): e04986, 2021 Nov.
Article
em En
| MEDLINE
| ID: mdl-34765202
ABSTRACT
Angiogenesis inhibitors (AGI) are not presently used for the treatment of gastric cancers. This report demonstrates that angiogenesis inhibitor can be safely and effectively used in combination with cytotoxic anti-cancer agents for treatment of Gastric cancers.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article